Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.
Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.
Payment is made upfront in ASRs, and the repurchase is facilitated by investment banks. This strategy can promptly enhance shareholder value by increasing earnings per share. Key findings are ...